Fortem GenusAcquired

iDetect — Non-Invasive COVID-19 Detection

Scalable COVID-19 detection using eye images and explainable AI — delivering 97% sensitivity, 350ms inference, and a strategic acquisition.

Computer VisionMedical AIMLOpsAWSExplainable AI
97%
Sensitivity
Clinical validation
350ms
Inference Time
Average latency
1,400
Tests/Day
Per deployment
$20M
Market Interest
First year
iDetect AI-powered eye scan for COVID-19 detection
The Challenge

Why Existing Solutions Fell Short

Hospitals and public health organizations faced critical constraints during the pandemic that demanded a new approach.

Invasive, Slow Testing

Nasopharyngeal swabs caused patient discomfort and slow turnaround times, limiting testing capacity during surge periods.

Limited Throughput

Constrained testing capacity impacted public health responses and hospital patient flow during peak demand.

High Operational Costs

Dependency on supply chains for swabs, reagents, and specialized equipment drove up per-test costs.

Black-Box ML Models

Lack of explainability in existing AI solutions hindered clinical adoption and regulatory approval pathways.

Business Impact

These constraints directly affected healthcare operations

Reduced Screening

Limited testing capacity

Extended Stays

Longer hospital admissions

Lost Revenue

Missed diagnostic opportunities

Slow Adoption

Black-box AI distrust

Our Approach

From Discovery to Deployment

A product-focused, regulatory-aware engineering approach: rapid discovery, robust development, and clinical validation.

01

Discovery & Clinical Alignment

We started with deep stakeholder engagement to understand clinical requirements and define success metrics.

  • Conducted interviews with clinicians, lab managers, and compliance officers
  • Defined clinical endpoints: sensitivity, specificity, and latency targets
  • Designed human-in-the-loop validation for investigational device requirements
The Solution

Technical Architecture

Enterprise-grade ML infrastructure built for clinical deployment and regulatory compliance.

Data Ingestion

Secure upload, de-identification, and preprocessing pipeline for ocular images.

Hybrid Model

Custom CNN backbone + SVM ensemble, trained with augmentation and demographic balancing.

Explainability

LIME + Guided Backprop overlays surface features for clinician interpretation.

Serving

Dockerized model endpoints on Kubernetes, autoscaling based on request load.

Observability

MLflow + Prometheus + Grafana for model metrics, drift detection, and latency tracking.

Security

HIPAA-compliant Azure tenancy for PII, SOC 2 Type II controls in place.

Tech Stack
AWS EC2AWS EC2
AzureAzure
PythonPython
PyTorchPyTorch
MLflowMLflow
DockerDocker
KubernetesKubernetes
CNNCNN
SageMakerSageMaker
MilvusMilvus
AWS EC2AWS EC2
AzureAzure
PythonPython
PyTorchPyTorch
MLflowMLflow
DockerDocker
KubernetesKubernetes
CNNCNN
SageMakerSageMaker
MilvusMilvus
Outcomes & Impact

Quantifiable Results

Real metrics from clinical deployment and commercial validation.

0%
Sensitivity
On validation cohorts
350ms
Inference Latency
Average response time
1.4K
Tests/Day
Scales horizontally
$20M
Market Interest
Strategic acquisition

Before → After Transformation

Metric
Before
After
Test Invasiveness
Nasopharyngeal swab
Non-invasive ocular image
Sensitivity
97%
Inference Latency
350 ms
Throughput
Limited
1,400/day (per deployment)
Commercial Interest
Low
$20M offer (within year)

Faster Triage

Reduced lab dependence and faster patient routing

Lower Costs

Reduced operational testing expenses

Patient Comfort

Non-invasive testing improves experience

Ready to Transform Your Diagnostics?

See Patient Impact in 30 Minutes

Book a personalized demo to see how CodefyU can build similar solutions for your healthcare organization.